文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

COVID-19重症成人ICU内非预期心脏骤停的发生率、临床特征与结局:多中心前瞻性ACICOVID-19登记研究

Incidence, clinical characteristics, and outcome after unexpected cardiac arrest among critically ill adults with COVID-19: insight from the multicenter prospective ACICOVID-19 registry.
PubMed 文献 · Ann Intensive Care · 2021-11-13
一句话结论法国35个ICU前瞻性登记显示,COVID-19重症患者ICU内心脏骤停发生率为8%,接受CPR者21%在3个月时功能结局良好(mRS 0–3)。

该研究为法国35个ICU的前瞻性登记,纳入2020年3–6月收治的2425例COVID-19成人患者,其中186例(8%)发生ICU内心脏骤停,146例(78%)接受CPR。接受CPR者中117例(80%)恢复自主循环,102例(70%)在ICU死亡,其中48例在骤停后第1天内死亡、21例在撤除生命支持后死亡;骤停时90%为不可除颤心律,90%接受机械通气,57%使用血管活性药,51%存在约三个器官衰竭。30例(21%)结局良好(骤停后90天mRS 0–3);多因素分析中,骤停前SOFA评分>9是唯一始终与不良结局相关的参数。

要点

  • 2425例COVID-19 ICU患者中186例(8%)发生ICU内心脏骤停,146例(78%)接受CPR。
  • 接受CPR者中117例(80%)恢复自主循环,102例(70%)在ICU死亡,48例在骤停后第1天内死亡。
  • 接受CPR者中30例(21%)在骤停后90天达到良好功能结局(mRS 0–3)。
  • 骤停时90%为不可除颤心律,90%接受机械通气,57%使用血管活性药,51%存在约三个器官衰竭。
  • 多因素分析中,骤停前SOFA评分>9是唯一始终与不良结局相关的参数。

适用人群与场景

  • 法国35个ICU收治的COVID-19成人患者。
  • 纳入标准:ICU内发生心脏骤停并尝试心肺复苏的COVID-19成人患者。

诊断标准与关键阈值

  • 良好结局定义为心脏骤停后第90天改良Rankin量表(mRS)0–3分。
  • 骤停前脓毒症相关器官衰竭评估(SOFA)评分>9与不良结局相关。

研究设计与关键结果

  • 研究类型:法国35个ICU的前瞻性登记研究(ACICOVID-19),纳入2020年3–6月收治的2425例COVID-19成人患者。
  • 186例(8%)发生ICU内心脏骤停,其中146例(78%)接受CPR。
  • 接受CPR的146例中,117例(80%)恢复自主循环,102例(70%)在ICU死亡,包括48例在骤停后第1天内死亡和21例在撤除生命支持治疗后死亡。
  • 骤停时90%为不可除颤心律;132例(90%)接受机械通气,83例(57%)使用血管活性药,75例(51%)存在约三个器官衰竭。
  • 30例(21%)结局良好(骤停后90天mRS 0–3)。
  • 多因素分析中,骤停前SOFA评分>9是唯一始终与不良结局相关的参数。

证据类型、等级与局限

  • 证据类型:多中心前瞻性登记研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,尽管ICU内心脏骤停发生率仍高,但接受CPR的COVID-19患者中21%在3个月时仍存活且功能状态良好,这与近期其他报告显示的较差结局形成对比。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Initial reports have described the poor outcome of unexpected cardiac arrest (CA) in intensive care unit (ICU) among COVID-19 patients in China and the USA. However, there are scarce data on characteristics and outcomes of such CA patients in Europe.

METHODS: Prospective registry in 35 French ICUs, including all in-ICU CA in COVID-19 adult patients with cardiopulmonary resuscitation (CPR) attempt. Favorable outcome was defined as modified Rankin scale ranging from 0 to 3 at day 90 after CA.

RESULTS: Among the 2425 COVID-19 patients admitted to ICU from March to June 2020, 186 (8%) experienced in-ICU CA, of whom 146/186 (78%) received CPR. Among these 146 patients, 117 (80%) had sustained return of spontaneous circulation, 102 (70%) died in the ICU, including 48 dying within the first day after CA occurrence and 21 after withdrawal of life-sustaining therapy. Most of CA were non-shockable rhythm (90%). At CA occurrence, 132 patients (90%) were mechanically ventilated, 83 (57%) received vasopressors and 75 (51%) had almost three organ failures. Thirty patients (21%) had a favorable outcome. Sepsis-related organ failure assessment score > 9 before CA occurrence was the single parameter constantly associated with unfavorable outcome in multivariate analysis.

CONCLUSIONS: In-ICU CA incidence remains high among a large multicenter cohort of French critically ill adults with COVID-19. However, 21% of patients with CPR attempt remained alive at 3 months with good functional status. This contrasts with other recent reports showing poor outcome in such patients.

TRIAL REGISTRATION: This study was retrospectively registered in ClinicalTrials.gov (NTC04373759) in April 2020 ( https://www.clinicaltrials.gov/ct2/show/NCT04373759?term=acicovid&draw=2&rank=1 ).

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Chelly J, Plantefève G, Kamel T, et al. Incidence, clinical characteristics, and outcome after unexpected cardiac arrest among critically ill adults with COVID-19: insight from the multicenter prospective ACICOVID-19 registry. Ann Intensive Care. 2021. PMID: 34773516. doi:10.1186/s13613-021-00945-y

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。